Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 6 | 2013 | 184 | 0.810 |
Why?
|
| Infant, Extremely Premature | 2 | 2013 | 11 | 0.530 |
Why?
|
| Enterotoxins | 2 | 2003 | 5 | 0.440 |
Why?
|
| Endotoxins | 2 | 2003 | 28 | 0.420 |
Why?
|
| Directive Counseling | 1 | 2012 | 14 | 0.410 |
Why?
|
| Professional-Family Relations | 1 | 2012 | 28 | 0.410 |
Why?
|
| Social Perception | 1 | 2012 | 23 | 0.410 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 2 | 2010 | 3 | 0.400 |
Why?
|
| Parents | 4 | 2017 | 110 | 0.380 |
Why?
|
| Sepsis | 2 | 2003 | 153 | 0.380 |
Why?
|
| Communication | 1 | 2012 | 120 | 0.370 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 161 | 0.370 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 232 | 0.360 |
Why?
|
| Rats | 8 | 2013 | 870 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2010 | 467 | 0.340 |
Why?
|
| Itraconazole | 1 | 2008 | 4 | 0.310 |
Why?
|
| Antifungal Agents | 1 | 2008 | 39 | 0.300 |
Why?
|
| Decision Making | 3 | 2017 | 236 | 0.290 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2005 | 165 | 0.280 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2010 | 5 | 0.260 |
Why?
|
| Lipopolysaccharides | 2 | 2003 | 133 | 0.260 |
Why?
|
| Anthropometry | 1 | 2005 | 39 | 0.260 |
Why?
|
| Interferon-gamma | 2 | 2003 | 111 | 0.250 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2004 | 1 | 0.240 |
Why?
|
| Catheterization | 1 | 2004 | 48 | 0.240 |
Why?
|
| Anesthetics | 1 | 2004 | 24 | 0.240 |
Why?
|
| Infant, Newborn | 7 | 2013 | 636 | 0.230 |
Why?
|
| Superantigens | 1 | 2003 | 3 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2003 | 13 | 0.220 |
Why?
|
| Acidosis, Lactic | 1 | 2002 | 2 | 0.210 |
Why?
|
| Lactates | 1 | 2002 | 7 | 0.210 |
Why?
|
| Hydrochloric Acid | 1 | 2002 | 1 | 0.210 |
Why?
|
| Animals | 8 | 2013 | 4713 | 0.210 |
Why?
|
| Citric Acid | 1 | 2002 | 3 | 0.210 |
Why?
|
| Peptic Ulcer | 1 | 2002 | 6 | 0.210 |
Why?
|
| Gastric Acid | 1 | 2002 | 9 | 0.210 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 88 | 0.210 |
Why?
|
| Liver Diseases | 1 | 2003 | 41 | 0.210 |
Why?
|
| Spleen | 1 | 2002 | 55 | 0.200 |
Why?
|
| Life Support Care | 3 | 2017 | 14 | 0.200 |
Why?
|
| Male | 12 | 2017 | 16488 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2002 | 254 | 0.170 |
Why?
|
| Documentation | 1 | 2018 | 33 | 0.160 |
Why?
|
| Fetal Viability | 1 | 2017 | 1 | 0.150 |
Why?
|
| Qualitative Research | 3 | 2017 | 117 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2018 | 69 | 0.150 |
Why?
|
| Truth Disclosure | 3 | 2012 | 11 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 159 | 0.140 |
Why?
|
| Pregnancy | 5 | 2017 | 404 | 0.120 |
Why?
|
| Perinatal Care | 1 | 2013 | 5 | 0.110 |
Why?
|
| Counseling | 1 | 2013 | 49 | 0.110 |
Why?
|
| Bile | 2 | 2003 | 6 | 0.110 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2013 | 1 | 0.110 |
Why?
|
| Bile Acids and Salts | 2 | 2003 | 11 | 0.110 |
Why?
|
| Thiazoles | 1 | 2013 | 31 | 0.110 |
Why?
|
| Biological Availability | 2 | 2013 | 25 | 0.100 |
Why?
|
| Alanine Transaminase | 2 | 2003 | 24 | 0.100 |
Why?
|
| Tape Recording | 1 | 2012 | 5 | 0.100 |
Why?
|
| Interview, Psychological | 1 | 2012 | 36 | 0.100 |
Why?
|
| Kidney Diseases | 2 | 2005 | 121 | 0.100 |
Why?
|
| Peer Group | 1 | 2012 | 42 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2013 | 146 | 0.100 |
Why?
|
| Palliative Care | 1 | 2013 | 154 | 0.100 |
Why?
|
| Cranial Sinuses | 1 | 2011 | 5 | 0.100 |
Why?
|
| Fetal Diseases | 1 | 2011 | 7 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2011 | 6 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2011 | 18 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2003 | 234 | 0.100 |
Why?
|
| Hospitals | 1 | 2012 | 165 | 0.090 |
Why?
|
| Attitude to Death | 1 | 2011 | 16 | 0.090 |
Why?
|
| Premature Birth | 1 | 2011 | 11 | 0.090 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2011 | 21 | 0.090 |
Why?
|
| Humans | 11 | 2018 | 31059 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 190 | 0.090 |
Why?
|
| Erythromycin | 1 | 2010 | 10 | 0.090 |
Why?
|
| Adult | 6 | 2013 | 8945 | 0.080 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2010 | 2 | 0.080 |
Why?
|
| Female | 8 | 2017 | 17005 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1506 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 1321 | 0.070 |
Why?
|
| Intensive Care, Neonatal | 1 | 2005 | 35 | 0.060 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2005 | 3 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 52 | 0.060 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 10 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2005 | 11 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2005 | 94 | 0.060 |
Why?
|
| Vasculitis | 1 | 2005 | 31 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 99 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2005 | 50 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 55 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2004 | 113 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 144 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2003 | 3 | 0.050 |
Why?
|
| Indocyanine Green | 1 | 2003 | 3 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2003 | 26 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2003 | 23 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 57 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 13 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 79 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2003 | 62 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 3 | 0.050 |
Why?
|
| Food, Formulated | 1 | 2002 | 6 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2002 | 91 | 0.050 |
Why?
|
| Portal Vein | 1 | 2003 | 42 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hypokalemia | 1 | 2002 | 7 | 0.050 |
Why?
|
| Alkalosis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Splenectomy | 1 | 2002 | 7 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2002 | 326 | 0.050 |
Why?
|
| Hypertension | 1 | 2002 | 288 | 0.040 |
Why?
|
| Nursing Methodology Research | 2 | 2011 | 26 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2018 | 70 | 0.040 |
Why?
|
| Health Personnel | 1 | 2018 | 118 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2002 | 1897 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2018 | 165 | 0.030 |
Why?
|
| Syndrome | 2 | 2005 | 83 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2013 | 8 | 0.030 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 5 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 29 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 1210 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 139 | 0.030 |
Why?
|
| Meglumine | 1 | 2011 | 2 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 78 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2011 | 10 | 0.020 |
Why?
|
| Neonatal Nursing | 1 | 2011 | 21 | 0.020 |
Why?
|
| Life Change Events | 1 | 2011 | 38 | 0.020 |
Why?
|
| Contrast Media | 1 | 2011 | 136 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2010 | 2 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 2 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 9 | 0.020 |
Why?
|
| Midazolam | 1 | 2010 | 12 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 62 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 70 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 227 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 239 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 185 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2010 | 222 | 0.020 |
Why?
|
| Mothers | 1 | 2011 | 184 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 346 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 416 | 0.020 |
Why?
|
| Role | 1 | 2005 | 8 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2005 | 29 | 0.020 |
Why?
|
| Informed Consent | 1 | 2005 | 22 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2005 | 20 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 52 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 2005 | 26 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2005 | 10 | 0.020 |
Why?
|
| Peroxidase | 1 | 2005 | 18 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2005 | 17 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2005 | 23 | 0.020 |
Why?
|
| Autoantigens | 1 | 2005 | 39 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2005 | 30 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2005 | 63 | 0.020 |
Why?
|
| Emergencies | 1 | 2005 | 41 | 0.020 |
Why?
|
| Dyspnea | 1 | 2005 | 44 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2005 | 81 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 2057 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 155 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 427 | 0.010 |
Why?
|
| Spironolactone | 1 | 2002 | 3 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2002 | 3 | 0.010 |
Why?
|
| Amiloride | 1 | 2002 | 7 | 0.010 |
Why?
|
| Electrolytes | 1 | 2002 | 14 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2002 | 24 | 0.010 |
Why?
|
| Diuretics | 1 | 2002 | 17 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3664 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2002 | 60 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2002 | 262 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 271 | 0.010 |
Why?
|